Zyvox Phase IV Studies May Support Penicillin-Resistant Indications
Executive Summary
Pharmacia will continue to seek additional indications for Zyvox (linezolid) in the treatment of antibiotic-resistant infections.
You may also be interested in...
Dalvance: First QIDP Antibiotic Breaks New Regulatory Ground; Label Doesn’t
Durata has post-marketing requirements to continue resistance-related studies, but its label includes stewardship language similar to other antibiotics.
FDA Wants Promotional “Targets” From Sponsors Throughout Drug Development
Sponsors should provide FDA with proposed promotional claims at the beginning of the drug development process, the agency said in a draft guidance
FDA Wants Promotional “Targets” From Sponsors Throughout Drug Development
Sponsors should provide FDA with proposed promotional claims at the beginning of the drug development process, the agency said in a draft guidance